Current progress and questions in germline genetics of prostate cancer

William B. Isaacs, Jianfeng Xu

Research output: Contribution to journalReview article

Abstract

Dramatic progress has been made in the area of germline genetics of prostate cancer (PCa) in the past decade. Both common and rare genetic variants with effects on risk ranging from barely detectable to outright practice-changing have been identified. For men with high risk PCa, the application of genetic testing for inherited pathogenic mutations is becoming standard of care. A major question exists about which additional populations of men to test, as men at all risk levels can potentially benefit by knowing their unique genetic profile of germline susceptibility variants. This article will provide a brief overview of some current issues in understanding inherited susceptibility for PCa.

Original languageEnglish (US)
Pages (from-to)3-9
Number of pages7
JournalAsian Journal of Urology
Volume6
Issue number1
DOIs
StatePublished - Jan 2019

Fingerprint

Prostatic Neoplasms
Genetic Testing
Standard of Care
Mutation
Population

Keywords

  • BRCA2
  • Genetic susceptibility
  • Germline genetics
  • Mutations
  • Prostate cancer
  • Single-nucleotide polymorphisms

ASJC Scopus subject areas

  • Urology

Cite this

Current progress and questions in germline genetics of prostate cancer. / Isaacs, William B.; Xu, Jianfeng.

In: Asian Journal of Urology, Vol. 6, No. 1, 01.2019, p. 3-9.

Research output: Contribution to journalReview article

@article{c3535816dfd347d09356c5d0141016b5,
title = "Current progress and questions in germline genetics of prostate cancer",
abstract = "Dramatic progress has been made in the area of germline genetics of prostate cancer (PCa) in the past decade. Both common and rare genetic variants with effects on risk ranging from barely detectable to outright practice-changing have been identified. For men with high risk PCa, the application of genetic testing for inherited pathogenic mutations is becoming standard of care. A major question exists about which additional populations of men to test, as men at all risk levels can potentially benefit by knowing their unique genetic profile of germline susceptibility variants. This article will provide a brief overview of some current issues in understanding inherited susceptibility for PCa.",
keywords = "BRCA2, Genetic susceptibility, Germline genetics, Mutations, Prostate cancer, Single-nucleotide polymorphisms",
author = "Isaacs, {William B.} and Jianfeng Xu",
year = "2019",
month = "1",
doi = "10.1016/j.ajur.2018.10.001",
language = "English (US)",
volume = "6",
pages = "3--9",
journal = "Asian Journal of Urology",
issn = "2214-3882",
publisher = "Elsevier (Singapore) Pte Ltd",
number = "1",

}

TY - JOUR

T1 - Current progress and questions in germline genetics of prostate cancer

AU - Isaacs, William B.

AU - Xu, Jianfeng

PY - 2019/1

Y1 - 2019/1

N2 - Dramatic progress has been made in the area of germline genetics of prostate cancer (PCa) in the past decade. Both common and rare genetic variants with effects on risk ranging from barely detectable to outright practice-changing have been identified. For men with high risk PCa, the application of genetic testing for inherited pathogenic mutations is becoming standard of care. A major question exists about which additional populations of men to test, as men at all risk levels can potentially benefit by knowing their unique genetic profile of germline susceptibility variants. This article will provide a brief overview of some current issues in understanding inherited susceptibility for PCa.

AB - Dramatic progress has been made in the area of germline genetics of prostate cancer (PCa) in the past decade. Both common and rare genetic variants with effects on risk ranging from barely detectable to outright practice-changing have been identified. For men with high risk PCa, the application of genetic testing for inherited pathogenic mutations is becoming standard of care. A major question exists about which additional populations of men to test, as men at all risk levels can potentially benefit by knowing their unique genetic profile of germline susceptibility variants. This article will provide a brief overview of some current issues in understanding inherited susceptibility for PCa.

KW - BRCA2

KW - Genetic susceptibility

KW - Germline genetics

KW - Mutations

KW - Prostate cancer

KW - Single-nucleotide polymorphisms

UR - http://www.scopus.com/inward/record.url?scp=85075785222&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075785222&partnerID=8YFLogxK

U2 - 10.1016/j.ajur.2018.10.001

DO - 10.1016/j.ajur.2018.10.001

M3 - Review article

C2 - 30775244

AN - SCOPUS:85075785222

VL - 6

SP - 3

EP - 9

JO - Asian Journal of Urology

JF - Asian Journal of Urology

SN - 2214-3882

IS - 1

ER -